These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 19773328)
21. Tumour markers - new aspects of an old discussion? Fleischhacker M; Beinert T Eur J Med Res; 1999 Apr; 4(4):144-8. PubMed ID: 10205289 [TBL] [Abstract][Full Text] [Related]
22. [Tumor markers--serologic parameters for monitoring and therapeutic control of cancer patients]. Birkmayer J Wien Med Wochenschr; 1988 Jun; 138(11-12):276-8. PubMed ID: 3176507 [TBL] [Abstract][Full Text] [Related]
23. Epitomics: serum screening for the early detection of cancer on microarrays using complex panels of tumor antigens. Draghici S; Chatterjee M; Tainsky MA Expert Rev Mol Diagn; 2005 Sep; 5(5):735-43. PubMed ID: 16149876 [TBL] [Abstract][Full Text] [Related]
24. Serum proteomic profiling by matrix-assisted laser desorption-ionization time-of-flight mass spectrometry for cancer diagnosis: next steps. Diamandis EP Cancer Res; 2006 Jun; 66(11):5540-1. PubMed ID: 16740686 [No Abstract] [Full Text] [Related]
25. Screening without evidence of efficacy. Law M BMJ; 2004 Feb; 328(7435):301-2. PubMed ID: 14764465 [No Abstract] [Full Text] [Related]
27. Can cancer be diagnosed with a blood test during routine examinations? Weiss PA; Weiss PA Clin J Oncol Nurs; 2007 Dec; 11(6):940-1. PubMed ID: 18063553 [TBL] [Abstract][Full Text] [Related]
28. Circulating tumour markers in ovarian tumours. von Schlippe M; Rustin GJ Forum (Genova); 2000; 10(4):383-92. PubMed ID: 11535987 [TBL] [Abstract][Full Text] [Related]
29. Invited commentary: Prostate cancer: doing less might be more. Comment on "Severity of comorbidity and non-prostate cancer mortality in men with early-stage prostate cancer". Ablin RJ; Sartor O; Bennett CL Arch Intern Med; 2010 Aug; 170(15):1397-9. PubMed ID: 20696969 [No Abstract] [Full Text] [Related]
30. CA-125: a biomarker put to the test. Schmidt C J Natl Cancer Inst; 2011 Sep; 103(17):1290-1. PubMed ID: 21852262 [No Abstract] [Full Text] [Related]
31. Electrochemical and chemiluminescent immunosensors for tumor markers. Lin J; Ju H Biosens Bioelectron; 2005 Feb; 20(8):1461-70. PubMed ID: 15626599 [TBL] [Abstract][Full Text] [Related]
33. Improper use of tumour markers as cancer screening tests among Greek physicians. Ntaios G; Hatzitolios A; Savopoulos C Eur J Intern Med; 2009 Sep; 20(5):e128. PubMed ID: 19712837 [No Abstract] [Full Text] [Related]
34. Evidence for the clinical use of tumour markers. Duffy MJ Ann Clin Biochem; 2004 Sep; 41(Pt 5):370-7. PubMed ID: 15333188 [TBL] [Abstract][Full Text] [Related]
36. [Tumor markers in the diagnosis of solid tumors]. Koch OM Internist (Berl); 1992 Aug; 33(8):W79-86. PubMed ID: 1526714 [No Abstract] [Full Text] [Related]
37. The clinical use of human tumour markers. Neville AM Ann Chir Gynaecol; 1989; 78(1):7-12. PubMed ID: 2667450 [No Abstract] [Full Text] [Related]
38. Introduction to tumor markers from A to Z. Plaut D MLO Med Lab Obs; 2004 Aug; 36(8):22, 26. PubMed ID: 15366364 [No Abstract] [Full Text] [Related]